GILEAD SCIENCES, INC. (GILD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 15B 30B 45B Q3 '21: 27.5B Q4 '21: 27.3B Q1 '22: 27.5B Q2 '22: 27.5B Q3 '22: 27.1B Q4 '22: 27.3B Q1 '23: 27B Q2 '23: 27.4B Q3 '23: 27.4B Q4 '23: 27.1B Q1 '24: 27.4B Q2 '24: 27.8B Q3 '24: 28.3B Q4 '24: 28.8B Q1 '25: 28.7B Q2 '25: 28.9B Q3 '25: 29.1B Q4 '25: 29.4B Q1 '26: 29.7B Q2 '26: 30.5B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 10B 20B 30B Q1 '16: 28.1B Q2 '16: 27.8B Q3 '16: 26.9B Q4 '16: 25.7B Q1 '17: 24.6B Q2 '17: 23.8B Q3 '17: 22.9B Q4 '17: 21.3B Q1 '18: 19.9B Q2 '18: 18.3B Q3 '18: 17.3B Q4 '18: 16.8B Q1 '19: 17.1B Q2 '19: 17.3B Q3 '19: 17.4B Q4 '19: 17.4B Q1 '20: 17.7B Q2 '20: 17.1B Q3 '20: 18B Q4 '20: 19.8B Q2 '16 Q1 '17 Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q4 '20

Operating Income TTM

-4B 0 4B 8B 12B Q3 '21: 11.6B Q4 '21: 9.9B Q1 '22: 7.2B Q2 '22: 7B Q3 '22: 6B Q4 '22: 7.3B Q1 '23: 8.8B Q2 '23: 8.5B Q3 '23: 8.3B Q4 '23: 7.6B Q1 '24: 1.6B Q2 '24: 2.6B Q3 '24: 822M Q4 '24: 1.7B Q1 '25: 8.2B Q2 '25: 8.1B Q3 '25: 10.5B Q4 '25: 10B Q1 '26: 10.4B Q2 '26: -2.5B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-3.5B 0 3.5B 7B 10.5B Q3 '21: 7.4B Q4 '21: 6.2B Q1 '22: 4.5B Q2 '22: 4.1B Q3 '22: 3.3B Q4 '22: 4.6B Q1 '23: 5.6B Q2 '23: 5.5B Q3 '23: 5.9B Q4 '23: 5.7B Q1 '24: 484M Q2 '24: 1.1B Q3 '24: 126M Q4 '24: 480M Q1 '25: 6B Q2 '25: 6.3B Q3 '25: 8.1B Q4 '25: 8.5B Q1 '26: 9.2B Q2 '26: -3.2B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 2.5B 5B 7.5B Q3 '21: 5.4B Q4 '21: 6.6B Q1 '22: 6.7B Q2 '22: 6.7B Q3 '22: 6.9B Q4 '22: 5.7B Q1 '23: 5.6B Q2 '23: 5.6B Q3 '23: 5.8B Q4 '23: 6.5B Q1 '24: 6.6B Q2 '24: 6.8B Q3 '24: 6.8B Q4 '24: 6.3B Q1 '25: 6.2B Q2 '25: 6.2B Q3 '25: 6.2B Q4 '25: 6.2B Q1 '26: 6.1B Q2 '26: 6.2B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 5B 10B 15B Q3 '21: 10.1B Q4 '21: 11.4B Q1 '22: 10.6B Q2 '22: 10.1B Q3 '22: 9.7B Q4 '22: 9.1B Q1 '23: 9B Q2 '23: 9.5B Q3 '23: 8.4B Q4 '23: 8B Q1 '24: 8.5B Q2 '24: 7.5B Q3 '24: 10B Q4 '24: 10.8B Q1 '25: 10.4B Q2 '25: 9.9B Q3 '25: 9.7B Q4 '25: 10B Q1 '26: 10.8B Q2 '26: 13.6B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 5B 10B 15B Q3 '21: 9.5B Q4 '21: 10.8B Q1 '22: 10B Q2 '22: 9.4B Q3 '22: 9B Q4 '22: 8.3B Q1 '23: 8.4B Q2 '23: 8.9B Q3 '23: 7.9B Q4 '23: 7.4B Q1 '24: 7.9B Q2 '24: 6.9B Q3 '24: 9.4B Q4 '24: 10.3B Q1 '25: 9.8B Q2 '25: 9.4B Q3 '25: 9.2B Q4 '25: 9.5B Q1 '26: 10.2B Q2 '26: 12.9B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 500M 1B 1.5B Q1 '20: 1.3B Q2 '20: 1.3B Q3 '20: 1.3B Q1 '21: 1.3B Q2 '21: 1.3B Q3 '21: 1.3B Q1 '22: 1.3B Q2 '22: 1.3B Q3 '22: 1.3B Q1 '23: 1.3B Q2 '23: 1.3B Q3 '23: 1.3B Q1 '24: 1.2B Q2 '24: 1.3B Q3 '24: 1.3B Q1 '25: 1.3B Q2 '25: 1.3B Q3 '25: 1.3B Q1 '26: 1.3B Q2 '26: 1.2B Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-5.00 -2.50 0.00 2.50 5.00 7.50 Q3 '21: 5.86 Q4 '21: 4.93 Q1 '22: 3.58 Q2 '22: 3.28 Q3 '22: 2.65 Q4 '22: 3.65 Q1 '23: 4.43 Q2 '23: 4.35 Q3 '23: 4.66 Q4 '23: 4.49 Q1 '24: 0.35 Q2 '24: 0.81 Q3 '24: 0.08 Q4 '24: 0.38 Q1 '25: 4.76 Q2 '25: 5.03 Q3 '25: 6.46 Q4 '25: 6.77 Q1 '26: 7.34 Q2 '26: -2.67 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.